Loading organizations...
Loading organizations...
Developer of a CMV-specific immunotoxin for infection eradication.
Synklino has raised $31.9M across 1 funding round.
Synklino has raised $31.9M in total across 1 funding round.
Synklino has raised $31.9M in total across 1 funding round.
Synklino's investors include Eir Ventures, PKA, Vaekstfonden.
Synklino has raised $31.9M across 1 funding round. Most recently, it raised $31.9M Series A in June 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 9, 2022 | $31.9M Series A | Eir Ventures, PKA, Vaekstfonden |